Sabra Health Care REIT (SBRA) has drawn fresh attention after a recent move in its share price, with the stock up about 11% over the past month and modestly higher over the past week.
Over the past 3 months the share price has declined slightly, even as Sabra Health Care REIT reports annual revenue of US$815.664 million and net income of US$156.185 million, giving investors a clearer picture of this US$5.1b healthcare-focused REIT.
See our latest analysis for Sabra Health Care REIT.
At the current share price of US$20.11, Sabra Health Care REIT shows a 10.98% 1 month share price return, while its 1 year total shareholder return of 18.38% points to momentum that has built over a longer period.
If Sabra Health Care REIT's recent move has you reassessing your portfolio, this can be a good moment to broaden your search with our screener of 39 healthcare AI stocks
Sabra Health Care REIT now trades at a meaningful discount to both one valuation estimate and the average analyst price target, even after the recent climb. Is the market rightly cautious about this healthcare REIT, or overly pessimistic about its prospects?
Sabra Health Care REIT's most followed narrative points to a fair value of $22.07 per share, compared with the latest close at $20.11, suggesting the valuation gap is still meaningful.
Persistent and accelerating demand for senior housing, assisted living, and memory care driven by the aging U.S. population, specifically the Baby Boomer cohort, continues to outpace new supply due to high barriers to development. This supports higher occupancy, rising rents, and long-term revenue and cash NOI growth across Sabra's property portfolio.
Curious what sits behind that fair value number? The narrative leans heavily on compounding revenue growth, firm margins, and a future earnings multiple that assumes investors keep paying up for this cash flow profile.
Result: Fair Value of $22.07 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still clear pressure points, including execution risk around new operators and the possibility that reimbursement changes could strain Sabra Health Care REIT's rent coverage and cash flows.
Find out about the key risks to this Sabra Health Care REIT narrative.
If the mixed sentiment around Sabra Health Care REIT leaves you undecided, take a closer look at both sides of the story and decide where you stand using our breakdown of 3 key rewards and 2 important warning signs
If Sabra Health Care REIT is just one piece of your watchlist, this is an opportunity to widen your search using targeted stock ideas from the Simply Wall St screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com